BlackRock Group’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

BlackRock Group’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-59,292	Closed	-$1M	–	2963
2014 Q4	$1M	Buy	59,292 +40,142	+210%	+$565K	﹤0.01%	1869
2014 Q3	$229K	Sell	19,150 -572	-3%	-$3.91K	﹤0.01%	2409
2014 Q2	$112K	Sell	19,722 -17,829	-47%	-$82.1K	﹤0.01%	2579
2014 Q1	$138K	Buy	37,551 +28,941	+336%	+$110K	﹤0.01%	2530
2013 Q4	$29K	Buy	+8,610	New	+$35.6K	﹤0.01%	2593

BlackRock Group's AVNR Position: Q1 2015 in Review

BlackRock Group sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 59,292 shares — an estimated $1M sold.

BlackRock Group first reported a position in AVNR in Q4 2013 and held it in 5 quarters. The position peaked at $1M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

BlackRock Group reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
BlackRock Group sold 59,292 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $1M.
BlackRock Group first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2013 and held it in 5 quarters.
BlackRock Group's AVANIR PHARMACEUTICALS, INC CL A position peaked at $1M in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on BlackRock Group's 13F filing for Q1 2015, filed 13 May 2015.